Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ZM Scientific is a small, private life science consulting and research business associated with antibody and protein engineering expertise in biotechnology and pharmaceuticals. Publicly available records indicate a Connecticut entity, ZM Scientific LLC, was formed in 2019, and a Swiss entity, ZM Scientific Consulting SNC, was established in Lausanne in 2023. The company appears to focus on high-level scientific consulting in protein and antibody engineering rather than operating a disclosed therapeutic pipeline. Leadership associated with ZM Scientific includes Eugene Zhukovsky and Richard Morse, with Zhukovsky described elsewhere as a co-founder and partner at ZM Scientific. Based on the limited public footprint, ZM Scientific looks more like a specialized advisory and scientific services firm than a venture-backed drug developer with named clinical assets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ZM Scientific.